Journal of Vaccine Research 2024, Vol.14, No.1, 1-9 http://medscipublisher.com/index.php/jvr 1 Research Report Open Access Analysis of Improvements to the Chickenpox Vaccine and the Development of New Vaccines Ping Feng, Danni Gu, Yanfei Wang People's Pharmacy Chain Co., Ltd., Changsha, 41000, Hunan, China Corresponding author: 1931515591@qq.com Journal of Vaccine Research, 2024, Vol.14, No.1 doi: 10.5376/jvr.2024.14.0001 Received: 17 Nov., 2023 Accepted: 20 Dec, 2023 Published: 01 Jan., 2024 Copyright © 2024 Feng et al., This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Preferred citation for this article: Feng P., Gu D.N., and Wang Y.F., 2024, Analysis of improvements to the chickenpox vaccine and the development of new vaccines, Journal of Vaccine Research, 14(1): 1-9 (doi: 10.5376/jvr.2024.14.0001) Abstract The improvement of the chickenpox vaccine and the development of new vaccines are of significant importance in preventing and controlling the spread of chickenpox. Chickenpox is a highly contagious disease, especially among children, and it can pose risks of complications and hospitalization. Enhancing the chickenpox vaccine can increase its protective efficacy and reduce the occurrence of adverse reactions. The development of new vaccines can meet the needs of specific populations and provide preventive measures on a global scale. Improvements in the chickenpox vaccine can enhance its protective efficacy and the duration of immunity. By refining the vaccine's formulation and production processes, the duration of immune protection can be prolonged, reducing the frequency of vaccination, and improving the vaccine's practicality and convenience. Furthermore, vaccine improvements can reduce the incidence of adverse reactions and side effects, increasing vaccine safety and acceptance. The development of new vaccines is crucial for addressing specific populations. Currently available chickenpox vaccines are generally suitable for children and adults, but they may not be suitable or effective for pregnant women, immunocompromised patients, and individuals with weakened immunity. Therefore, the development of new vaccines tailored to specific populations is necessary. This review briefly outlines the improvement of the chickenpox vaccine and the development of new vaccines, aiming to provide the public with a better understanding of chickenpox vaccines. This, in turn, can lead to improved prevention and control of chickenpox transmission, reducing the impact of chickenpox on individuals and society. Keywords Improvement of Chickenpox vaccine; International cooperation and collaborative efforts; Safety assessment and monitoring; Development of new vaccines; Promotion and popularization of vaccine immunization Chickenpox, also known as herpes zoster, is an acute infectious disease caused by the varicella-zoster virus. It is primarily transmitted through airborne droplets, with the virus entering the bodies of others through the respiratory system when an infected individual coughs, sneezes, or has close contact with others. Additionally, the varicella-zoster virus can also spread through direct contact with the skin lesions of the patient. Once infected with chickenpox, the body generates specific immune responses, but this does not imply complete immunity because the virus can lie dormant in nerve tissues, leading to the development of herpes zoster in the future. Chickenpox is a widely contagious disease, especially common among children. Patients typically experience fever, itchy rashes, and varying degrees of discomfort. While most chickenpox patients recover on their own, there is a risk of severe complications, such as skin infections, pneumonia, encephalitis, and herpes zoster. Furthermore, chickenpox can have a more severe impact on specific populations, such as pregnant women, individuals with compromised immune systems, and newborns. The introduction and widespread vaccination of the chickenpox vaccine can significantly reduce the incidence of chickenpox and the risk of complications. The vaccine works by activating the immune system in the human body, causing it to produce specific antibodies to combat the varicella-zoster virus. These antibodies can identify and neutralize the virus, thereby preventing further virus replication and infection of other cells. Through vaccination with the chickenpox vaccine, individuals can acquire long-term immune protection, reducing the occurrence and transmission of chickenpox. The importance of the chickenpox vaccine is not only evident at the individual level but also holds significant implications for public health. Widespread chickenpox vaccination can achieve herd
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==